Imatinib Completed Phase 2 Trials for Blastic Phase Chronic Myelogenous Leukemia / Relapsing Chronic Myelogenous Leukemia / Childhood Chronic Myelogenous Leukemia / Accelerated Phase Chronic Myelogenous Leukemia / Chronic Myelogenous Leukemia, BCR-ABL1 Positive Treatment